Tracxn's proprietary #taxonomy brings to you top #BusinessModels in Life Sciences rebrand.ly/b68f3u2 Get our free reports on #PracticeArea or #sector of your interest to your mailbox regularly https://rb.gy/cx2upn

1. TRACXN TOP BUSINESS MODELS REPORT
August 17, 2021
LIFE SCIENCES

2. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Contents
Life Sciences Funding - Overview 3
Top Funded Business Models 4
One pagers 9
Appendix 59
2

3. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Funding in last 1 year
3
Oncology $20.2B
Genomics $14.9B
Life Sciences Platforms and Tools $8.8B
Life Sciences Tech $7.8B
Diagnostics (by Technology) $6.6B
Immunology $4.5B
Y-o-Y Funding
Top Investors by Funding Rounds
Seed
Stage
Y Combinator
Illumina
HTGF
19
6
6
Early
Stage
RA Capital Management
Orbimed
Casdin Capital
31
25
25
Late
Stage
Orbimed
RA Capital Management
Fidelity Investments
35
27
20
Funding by Geography
Top Feeds by $ Funding
Top Funding Rounds
United States (67%)
China (13%)
United Kingdom (7%)
Switzerland (2%)
Canada (2%)
Germany (1%)
Israel (1%)
Others (7%)
$ Funding # Rounds
Caris Life Sciences
(1996, United States)
$830M - Series D
CMR Surgical
(2014, United Kingdom)
$600M - Series D
ElevateBio
(2018, United States)
$525M - Series C
Pivot Bio
(2010, United States)
$430M - Series D
Insitro
(2018, United States)
$400M - Series C
XtalPi
(2014, United States)
$400M - Series D
Adagio
(2020, United States)
$336M - Series C
XtalPi
(2014, United States)
$319M - Series C
LianBio
(1999, China)
$310M -
Unattributed
Element Biosciences
(2017, United States)
$276M - Series C
Nanopore
(2005, United Kingdom)
$271M - Series H
Freenome
(2014, United States)
$270M - Series C

4. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (1/5)
4
Rank Business Model $ Funding # Rounds Top Funding Round Details
1<> 0 Drugs for Multiple Cancer Types $11.9B 293 LianBio | $310M | Unattributed Link
2<> 0 Life Sciences Research Services $3.3B 208 Tessera Thera.. | $230M | Series B Link
3▲3 Sequencing-based Genomic Precision Medicine $2.0B 30 Caris Life Sc.. | $830M | Series D Link
4▼1 Gene Therapy Drugs $1.9B 52 Wugen | $172M | Series B Link
5▲13 Genomic Data Analysis Platforms $1.6B 18 Element Biosc.. | $276M | Series C Link
6▼1 Neurological Disorder Drugs $1.5B 51 Jaguar Gene T.. | $139M | Series B Link
7▲31 Gene Editing Platforms $1.4B 24 Tessera Thera.. | $230M | Series B Link
8▲7 Robot Assisted Surgery $1.3B 21 CMR Surgical | $600M | Series D Link
9▲5 Autoimmune Disorders Drugs $1.3B 24 Sonoma Biothe.. | $265M | Series B Link
10▼6 Pan-Cancer Drugs $1.2B 34 Hummingbird B.. | $125M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

5. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (2/5)
5
Rank Business Model $ Funding # Rounds Top Funding Round Details
11▲534 Pharmocogenomic Tests $1.2B 6 Caris Life Sc.. | $830M | Series D Link
12▼1 Cancer Diagnostic Tests $1.1B 18 Freenome | $270M | Series C Link
13▲31 Proteomics Research Services $1.1B 16 Somalogic | $212M | Series E Link
14▼2 Hematologic Cancer Drugs $1.1B 12 ElevateBio | $525M | Series C Link
15▼6 Neurodegenerative Disorders Drugs $962M 36 Sonoma Biothe.. | $265M | Series B Link
16▲12 Inflammatory Diseases Drugs $944M 24 Apollo Therap.. | $145M | Series A Link
17▼10 DNA Liquid Biopsy Diagnostics $719M 14 Genecast | $149M | Series E Link
18▲56 Diversified $645M 19 NewAmsterdam .. | $196M | Series A Link
19▲64 COVID-19 Drugs $642M 12 Adagio | $336M | Series C Link
20▼4 Diabetes Drugs $624M 25 Jaguar Gene T.. | $139M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

6. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (3/5)
6
Rank Business Model $ Funding # Rounds Top Funding Round Details
21<> 0 Nucleic Acid Sequencing Equipment $611M 11 Nanopore | $271M | Series H Link
22▼9 Synthetic Biology $581M 12 Pivot Bio | $430M | Series D Link
23▲11 At-Home Preventive Genetic Test Kits $579M 7 Everly Wellness | $175M | Series D Link
24▲21 Genomic Sequencing Instruments $570M 13 Nanopore | $271M | Series H Link
25▲93 Proteomic Based Diagnostic Tests $526M 8 Somalogic | $212M | Series E Link
26▲24 Agrigenomics $487M 14 Inari | $208M | Series D Link
27▼19 Retinal Disorders Drugs $481M 17 Vedere | $77.0M | Series A Link
28▼9 Genomic Biomarker Discovery Research $434M 6 Freenome | $270M | Series C Link
29▲53 Ophthalmology Drugs $433M 38 Gyroscope | $148M | Series C Link
30▲17 Genomics Based Drug Development Software $397M 8 Insilico | $255M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

7. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (4/5)
7
Rank Business Model $ Funding # Rounds Top Funding Round Details
31▲31 Metabolic Disorders Drugs $387M 32 VISEN Pharmac.. | $150M | Series B Link
32▲10 Ultrasound Imaging Devices $384M 10 Exo | $220M | Series C Link
33▼2 Anti Bacterial Drugs $380M 23 Affinivax | $226M | Series C Link
34▲25
Diagnostics (by Technology) > Diagnostic Software >
Imaging > Digital Pathology
$379M 9 PathAI | $165M | Series C Link
35▲49 Genome Engineering Services $361M 6 Artiva | $120M | Series B Link
36▲378 Molecular Modeling Solutions $361M 11 Cellarity | $123M | Series B Link
37▲80 Precision Medicine Software $358M 6 3DMed | $224M | Series D Link
38▲52 Genomic Research Models $353M 4 Biocytogen | $142M | Series D Link
39▲157
Diagnostics (by Technology) > Diagnostic Assays and
Systems > In vitro Diagnostics > Multi-om..
$352M 2 Freenome | $270M | Series C Link
40▼11 Genomics Research Services $349M 27 Caribou Biosc.. | $115M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

8. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (5/5)
8
Rank Business Model $ Funding # Rounds Top Funding Round Details
41▼17 Genomic Sequence Analysis Softwares $342M 13 Deep Genomics | $180M | Series C Link
42▲24 Cardiac Diagnostic Devices $339M 10 Imperative Care | $260M | Series D Link
43▲129 Neurological Pain Management Drugs $333M 20 Eliem Therap.. | $80.0M | Series C Link
44▲197 Nanoparticle Based Drug Delivery Systems $329M 10 Siwei Biotech.. | $188M | Series B Link
45▼20 Congestive Heart Failure Treatment Devices $324M 13 Ancora Heart | $80.0M | Series D Link
46▼36 RNA Interference Platforms $316M 4 Siwei Biotech.. | $188M | Series B Link
47▲82 Patient Recruitment Platforms for Clinical Trials $314M 9 Reify Health | $220M | Series C Link
48-- Valvular Disorder Drugs $313M 2 LianBio | $310M | Unattributed Link
49▲182 Life Sciences Research Instruments $305M 4 Esco | $200M | Series A Link
50▲91 Cancer Precision Medicine Diagnostic Tests $297M 12 ITM | $109M | Series D Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

9. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
LianBio (1999, China)
$310M - Unattributed - Oct 2020
Clover Biopharma (2007, China)
$230M - Series C - Feb 2021
Umoja Biopharma (2019, United States)
$210M - Series B - Jun 2021
D3 Bio (2018, China)
$200M - Series A - Nov 2020
CARsgen (2014, China)
$186M - Series C - Nov 2020
Pyxis Oncology (2018, United States)
$173M - Series B - Mar 2021
Vaccitech (2016, United Kingdom)
$168M - Series B - Mar 2021
View all 293 Funding Rounds on Tracxn Platform
Drugs for Multiple Cancer Types
01
9
Back to index
Oncology (Guardant Health)
(# Cos: 4274 | $93.1B)
Drugs (BioNTech)
(# Cos: 2735 | $71.3B)
Diversified (Moderna)
(# Cos: 2164 | $56.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$11.9B (▲47%)
293(▲29.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
189
$56.3B
1528
337
2164
263
Moderna
(2010, United States, $2.8B)
BioNTech
(2008, Germany, $806M)
Kite Pharma
(2009, United States, $97.7M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

10. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Life Sciences Research Services
02
10
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9455 | $48.8B)
Research Services (Ginkgo Bioworks)
(# Cos: 4971 | $32.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$3.3B (▼7%)
208(▼12.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
432
$32.8B
2402
241
4971
203
Ginkgo Bioworks
(2009, United States, $796M)
Ancestry
(1996, United States, $146M)
Horizon Discovery
(2007, United Kingdom, $46.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Tessera Thera.. (2018, United States)
$230M - Series B - Jan 2021
Somalogic (1999, United States)
$212M - Series E - Dec 2020
Nautilus Biot.. (2016, United States)
$200M - Series C - Jun 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Biocytogen (2008, United States)
$142M - Series D - Sep 2020
Vividion Ther.. (2016, United States)
$135M - Series C - Feb 2021
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
View all 208 Funding Rounds on Tracxn Platform

11. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sequencing-based Genomic Precision
Medicine
03
11
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$2.0B (▲158%)
30(▼11.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
31
$11.9B
190
48
363
29
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Applied Genomics (MyHeritage)
(# Cos: 3794 | $50.5B)
Clinical Genomics (Invitae)
(# Cos: 1975 | $37.4B)
Diagnostics (Adaptive Biotechnologies)
(# Cos: 1434 | $24.9B)
Sequencing-based (Guardant Health)
(# Cos: 1185 | $23.2B)
Precision Medicine (Bluebird Bio)
(# Cos: 363 | $11.9B)
Bluebird Bio
(1992, United States, $136M)
MiRagen
(2007, United States, $43.6M)
UniQure
(1998, Netherlands, $200M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Caris Life Sc.. (1996, United States)
$830M - Series D - May 2021
Caris Life Sc.. (1996, United States)
$235M - Unattributed - Oct 2020
Ambrx (2003, United States)
$200M - Series E - Nov 2020
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
Omega Therape.. (2016, United States)
$126M - Series C - Mar 2021
BerryOncology (2017, China)
$108M - Series B - Aug 2021
DTx Pharma (2017, United States)
$100M - Series B - Mar 2021
View all 30 Funding Rounds on Tracxn Platform

12. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Therapy Drugs
04
12
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.9B (▼27.4%)
52(▼14.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
54
$12.2B
341
76
515
64
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Applied Genomics (MyHeritage)
(# Cos: 3794 | $50.5B)
Clinical Genomics (Guardant Health)
(# Cos: 1975 | $37.4B)
Therapeutics (Spark Therapeutics)
(# Cos: 515 | $12.2B)
Spark Therapeutics
(2013, United States, $82.8M)
Verve
(2018, United States, $216M)
Alnylam
(2002, United States, $17.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Wugen (2018, United States)
$172M - Series B - Jul 2021
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Forge Biologics (2020, United States)
$120M - Series B - Apr 2021
Ring Therapeu.. (2018, United States)
$117M - Series B - Jul 2021
Neurogene (2001, United States)
$115M - Series B - Dec 2020
Sirnaomics (2007, United States)
$105M - Series E - Jul 2021
Sirnaomics (2007, United States)
$105M - Series D - Oct 2020
View all 52 Funding Rounds on Tracxn Platform

13. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Insilico (2014, China)
$255M - Series C - Jun 2021
3DMed (2010, China)
$224M - Series D - Oct 2020
Benchling (2012, United States)
$200M - Series E - Apr 2021
Singlera Geno.. (2014, United States)
$150M - Series B - Dec 2020
Singlera Geno.. (2014, United States)
$150M - Series B - Dec 2020
SOPHiA GENETICS (2011, Switzerland)
$110M - Series F - Oct 2020
View all 18 Funding Rounds on Tracxn Platform
Genomic Data Analysis Platforms
05
13
Back to index
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Genome Informatics (Quest Diagnostics)
(# Cos: 726 | $4.8B)
Integrative Bioinformatics Platforms
(Human Longevity)
(# Cos: 467 | $3.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.6B (▲259%)
18(▲12.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$3.9B
166
7
467
17
Human Longevity
(2013, United States, $330M)
Quest Diagnostics
(1967, United States)
Seer
(2017, United States, $128M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

14. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Neurelis (2007, United States)
$115M - Series D - Mar 2021
Edgewise Ther.. (2017, United States)
$95.0M - Series C - Dec 2020
Flare Therape.. (2021, United States)
$82.0M - Series A - May 2021
Faze Medicines (2019, United States)
$81.0M - Series A - Dec 2020
Pipeline Ther.. (2017, United States)
$80.0M - Series C - Feb 2021
Beckley Psyt.. (1998, United Kingdom)
$80.0M - Series B - Aug 2021
View all 51 Funding Rounds on Tracxn Platform
Neurological Disorder Drugs
06
14
Back to index
Neurology (Zogenix)
(# Cos: 2411 | $28.5B)
Drugs (Biogen)
(# Cos: 1308 | $22.1B)
Diversified (Biohaven Pharmaceutical)
(# Cos: 316 | $6.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.5B (▲83.9%)
51(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
31
$6.0B
224
50
316
40
Biohaven Pharmaceutical
(2014, United States, $84.1M)
Cerevance
(2015, United States, $106M)
PureTech Health
(2001, United States, $107M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

15. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Editing Platforms
07
15
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B (▲559%)
24(▲60%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$2.3B
61
3
91
15
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Enabling Technologies (Quanterix)
(# Cos: 1658 | $17.8B)
Technology Platforms (Moderna)
(# Cos: 360 | $9.8B)
Gene Editing (Horizon Discovery)
(# Cos: 91 | $2.3B)
Horizon Discovery
(2007, United Kingdom, $46.3M)
Locus Biosciences
(2015, United States, $32.3M)
Vineti
(2016, United States, $151M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Tessera Thera.. (2018, United States)
$230M - Series B - Jan 2021
Prime Medicine (2019, United States)
$200M - Series B - Jul 2021
Graphite Bio (2020, United States)
$151M - Series B - Mar 2021
Scribe Therap.. (2018, United States)
$100M - Series B - Mar 2021
Locana (2016, United States)
$100M - Series B - Dec 2020
Korro Bio (2018, United States)
$91.5M - Series A - Sep 2020
Remix Therape.. (2019, United States)
$81.0M - Series A - Dec 2020
View all 24 Funding Rounds on Tracxn Platform

16. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Robot Assisted Surgery
08
16
Back to index
Surgical Instruments (CMR Surgical)
(# Cos: 663 | $6.3B)
Robotic Surgery (Intuitive)
(# Cos: 170 | $4.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.3B (▲149%)
21(▲10.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
20
$4.1B
104
12
170
23
Intuitive
(1995, United States, $47.0M)
CMR Surgical
(2014, United Kingdom, $1.0B)
TransEnterix
(2006, United States, $96.2M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
CMR Surgical (2014, United Kingdom)
$600M - Series D - Jun 2021
eCential Robotics (2009, France)
$120M - Series C - Jan 2021
Memic Surgery (2013, Israel)
$96.0M - Series D - Apr 2021
Edge Medical Robotics (2017, China)
$92.6M - Series B - Jan 2021
PROCEPT BioRo.. (2009, United States)
$85.0M - Series G - Jun 2021
ColubrisMX (2017, United States)
$76.1M - Series C - Jun 2021
ColubrisMX (2017, United States)
$69.0M - Series B - May 2021
View all 21 Funding Rounds on Tracxn Platform

17. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
D3 Bio (2018, China)
$200M - Series A - Nov 2020
Ventyx Biosci.. (2018, United States)
$114M - Series D - Mar 2021
BioTheryX (2007, United States)
$92.1M - Series E - May 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Interius Biot.. (2020, United States)
$76.0M - Series A - May 2021
Tvardi (2017, United States)
$74.0M - Series B - Jun 2021
View all 24 Funding Rounds on Tracxn Platform
Autoimmune Disorders Drugs
09
17
Back to index
Immunology (DBV Technologies)
(# Cos: 830 | $20.3B)
Drugs (GigaGen)
(# Cos: 692 | $19.5B)
Autoimmune Diseases (Moderna)
(# Cos: 101 | $6.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.3B (▲140%)
24(▲41.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$6.3B
66
14
101
19
Moderna
(2010, United States, $2.8B)
X-37
(2019, United States, $14.5M)
Tvardi
(2017, United States, $83.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

18. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Hummingbird Biosc.. (2015, Singapore)
$125M - Series C - May 2021
Boundless Bio (2018, United States)
$106M - Series B - Apr 2021
Elpiscience (2017, China)
$105M - Series C - May 2021
Gracell Bio (2017, China)
$100M - Series C - Oct 2020
TScan Therape.. (1995, United States)
$100M - Series C - Jan 2021
Wuhan Binhui Biotechn.. (2010, China)
$94.9M - Series C - Feb 2021
LAVA therapeutics (2016, Netherlands)
$83.0M - Series C - Sep 2020
View all 34 Funding Rounds on Tracxn Platform
Pan-Cancer Drugs
10
18
Back to index
Oncology (Guardant Health)
(# Cos: 4274 | $93.1B)
Drugs (Moderna)
(# Cos: 2735 | $71.3B)
Pan Cancer (GigaGen)
(# Cos: 345 | $7.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.2B (▼28.3%)
34(▼26.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
25
$7.4B
224
43
345
41
GigaGen
(2011, United States, $36.1M)
TScan Therapeutics
(1995, United States, $180M)
Fusion Pharmaceuticals
(2014, Canada, $171M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

19. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Pharmocogenomic Tests
11
19
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.2B (▲ >10K%)
6(▲200%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
10
$1.9B
41
5
93
7
Diagnostics (by Technology) (Medtronic)
(# Cos: 5459 | $44.3B)
Diagnostic Assays and Systems (Adaptive
Biotechnologies)
(# Cos: 1613 | $21.1B)
In vitro Diagnostics (Guardant Health)
(# Cos: 1593 | $21.1B)
Nucleic Acid-based (23andMe)
(# Cos: 878 | $14.6B)
Sequencing-based (MyHeritage)
(# Cos: 660 | $11.8B)
Genomics (Illumina)
(# Cos: 613 | $11.1B)
Pharmacogenomics
(Foundation Medicine)
(# Cos: 93 | $1.9B)
Foundation Medicine
(2010, United States, $96.5M)
Caris Life Sciences
(1996, United States, $1.1B)
Interleukin Genetics
(1986, United States, $33.6M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Caris Life Sc.. (1996, United States)
$830M - Series D - May 2021
Caris Life Sc.. (1996, United States)
$235M - Unattributed - Oct 2020
Strata Oncology (2015, United States)
$90.0M - Series C - Jul 2021
Genomind (2009, United States)
$6.4M - Series D - Apr 2021
Strata Oncology (2015, United States)
$5.0M - Series B - Nov 2020
AltheaDx (2009, United States)
$3.7M - Series D - Dec 2020

20. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$270M - Series C - Aug 2020
Color (2013, United States)
$167M - Series D - Jan 2021
PathAI (2016, United States)
$165M - Series C - May 2021
Genecast (2016, China)
$149M - Series E - Oct 2020
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Personal Genome (2010, United States)
$103M - Series C - Feb 2021
NovellusDx (2011, Israel)
$57.0M - Series C - Sep 2020
View all 18 Funding Rounds on Tracxn Platform
Cancer Diagnostic Tests
12
20
Back to index
Oncology (Adaptive Biotechnologies)
(# Cos: 4274 | $93.1B)
In-Vitro Diagnostic Tests (Guardant Health)
(# Cos: 1094 | $17.6B)
Pan Cancer (GRAIL)
(# Cos: 198 | $5.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▲76%)
18(▼14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
23
$5.6B
126
9
198
19
GRAIL
(2016, United States, $2.0B)
Color
(2013, United States, $391M)
Biocartis
(2007, Belgium, $305M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

21. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Somalogic (1999, United States)
$212M - Series E - Dec 2020
Nautilus Biot.. (2016, United States)
$200M - Series C - Jun 2021
AbSci (2011, United States)
$125M - Series E - Mar 2021
Somalogic (1999, United States)
$121M - Series E - Nov 2020
Amunix (2006, United States)
$117M - Series B - Mar 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
AbSci (2011, United States)
$70.0M - Series E - Oct 2020
View all 16 Funding Rounds on Tracxn Platform
Proteomics Research Services
13
21
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9455 | $48.8B)
Research Services (Ginkgo Bioworks)
(# Cos: 4971 | $32.8B)
Proteomics (Atomwise)
(# Cos: 274 | $2.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▲486%)
16(▲45.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$2.5B
100
4
274
11
Atomwise
(2012, United States, $175M)
AbSci
(2011, United States, $223M)
ProteinSimple
(2004, United States, $94.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

22. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
ElevateBio (2018, United States)
$525M - Series C - Mar 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Monte Rosa Th.. (2020, United States)
$96.0M - Series B - Sep 2020
Monte Rosa Th.. (2020, United States)
$95.0M - Series C - Mar 2021
Ossium Health (2016, United States)
$63.0M - Series B - Mar 2021
Ajax (2019, United States)
$40.0M - Series C - Jun 2021
Priothera (2020, Ireland)
$35.5M - Series A - Oct 2020
View all 12 Funding Rounds on Tracxn Platform
Hematologic Cancer Drugs
14
22
Back to index
Oncology (Guardant Health)
(# Cos: 4274 | $93.1B)
Drugs (Moderna)
(# Cos: 2735 | $71.3B)
Blood Cancer (Sierra Oncology)
(# Cos: 83 | $4.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▲91.7%)
12(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$4.1B
64
20
83
11
Sierra Oncology
(2003, Canada, $75.0M)
Kiadis Pharma
(1997, Netherlands, $33.0M)
ASLAN Pharmaceuticals
(2010, Singapore, $100M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

23. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Amylyx Pharma.. (2013, United States)
$135M - Series C - Jul 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
LEXEO Therape.. (2018, United States)
$85.0M - Series A - Jan 2021
Muna Therapeutics (2020, Denmark)
$73.0M - Series A - Jul 2021
ESCAPE Bio (2015, United States)
$73.0M - Series C - Sep 2020
BioShin (2018, China)
$60.0M - Series A - Sep 2020
View all 36 Funding Rounds on Tracxn Platform
Neurodegenerative Disorders Drugs
15
23
Back to index
Neurology (Biohaven Pharmaceutical)
(# Cos: 2411 | $28.5B)
Drugs (Zogenix)
(# Cos: 1308 | $22.1B)
Neurodegenerative (Biogen)
(# Cos: 473 | $7.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$962M (▲38.3%)
36( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
29
$7.6B
321
51
473
46
Biogen
(1978, United States, $80.0M)
Frequency Therapeutics
(2015, United States, $136M)
Athira Pharma
(2011, United States, $109M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

24. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Apollo Thera.. (2007, United Kingdom)
$145M - Series A - Jun 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Flame Bioscie.. (2019, United States)
$100M - Series B - Sep 2020
Escient Pharm.. (2017, United States)
$77.5M - Series B - Sep 2020
Aristea Thera.. (2018, United States)
$63.0M - Series B - Jul 2021
Immune Regul.. (2011, United Kingdom)
$52.4M - Series B - Sep 2020
Be Bio (2020, United States)
$52.0M - Series A - Oct 2020
View all 24 Funding Rounds on Tracxn Platform
Inflammatory Diseases Drugs
16
24
Back to index
Immunology (GigaGen)
(# Cos: 830 | $20.3B)
Drugs (Moderna)
(# Cos: 692 | $19.5B)
Inflammatory Diseases (Nimbus
Therapeutics)
(# Cos: 220 | $3.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$944M (▲249%)
24(▲20%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
21
$3.6B
158
22
220
26
Nimbus Therapeutics
(2009, United States, $242M)
RedHill Biopharma
(2009, Israel, $13.5M)
Inflazome
(2016, Ireland, $65.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

25. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNA Liquid Biopsy Diagnostics
17
25
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$719M (▼8.1%)
14( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$4.5B
58
6
93
10
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Applied Genomics (MyHeritage)
(# Cos: 3794 | $50.5B)
Clinical Genomics (Natera)
(# Cos: 1975 | $37.4B)
Diagnostics (Invitae)
(# Cos: 1434 | $24.9B)
Sequencing-based (Adaptive
Biotechnologies)
(# Cos: 1185 | $23.2B)
Liquid Biopsy (GRAIL)
(# Cos: 166 | $5.3B)
DNA (Guardant Health)
(# Cos: 93 | $4.5B)
Guardant Health
(2012, United States, $558M)
GRAIL
(2016, United States, $2.0B)
Inivata
(2014, United Kingdom, $164M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Genecast (2016, China)
$149M - Series E - Oct 2020
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Delfi Diagnos.. (2019, United States)
$101M - Series A - Jan 2021
C2i Genomics (2019, United States)
$100M - Series B - Apr 2021
Scipher Medic.. (2014, United States)
$82.0M - Series C - Mar 2021
Nucleix (2008, Israel)
$55.0M - Series C - Apr 2021
Jiyinga Technology (2015, China)
$38.0M - Series B - Nov 2020
View all 14 Funding Rounds on Tracxn Platform

26. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
NewAmsterdam Ph.. (2019,
Netherlands)
$196M - Series A - Jan 2021
Tenaya Therap.. (2016, United States)
$106M - Series C - Mar 2021
TransThera Biosciences (2016, China)
$100M - Series D - Jul 2021
Ixaka (2009, United Kingdom)
$54.3M - Series C - Jan 2021
Rivus Pharmac.. (2019, United States)
$35.0M - Series A - Jun 2021
InCarda Thera.. (2009, United States)
$30.0M - Series C - Oct 2020
CiVi Biopharma (2016, United States)
$27.5M - Series B - Dec 2020
View all 19 Funding Rounds on Tracxn Platform
Diversified
18
26
Back to index
Cardiac and Vascular Disorders (Withings)
(# Cos: 2341 | $29.8B)
Drugs (Moderna)
(# Cos: 321 | $9.9B)
Diversified (Esperion Therapeutics)
(# Cos: 256 | $5.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$645M (▲404%)
19(▲138%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$5.6B
197
43
256
17
Esperion Therapeutics
(1998, United States, $130M)
MyoKardia
(2012, United States, $98.0M)
Tenaya Therapeutics
(2016, United States, $248M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

27. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
COVID-19 Drugs
19
27
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$642M (▲452%)
12(▲71.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$972M
34
5
62
9
Infectious Diseases (Oxford Immunotec)
(# Cos: 1856 | $26.2B)
Drugs (CureVac)
(# Cos: 1027 | $21.7B)
Viral (Moderna)
(# Cos: 449 | $11.8B)
COVID-19 (GigaGen)
(# Cos: 62 | $972M)
GigaGen
(2011, United States, $36.1M)
NantKwest
(2002, United States, $147M)
Adagio
(2020, United States, $466M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Adagio (2020, United States)
$336M - Series C - Apr 2021
Nano (2003, United States)
$90.0M - Series C - Mar 2021
Adagio (2020, United States)
$80.0M - Series B - Nov 2020
Touchlight (2008, United Kingdom)
$58.4M - Series B - Mar 2021
Vaxxinity (2019, United States)
$27.0M - Series B - Mar 2021
ExeVir Bio (2020, Belgium)
$22.7M - Series A - Mar 2021
PharmCADD (2019, South Korea)
$15.5M - Series B - Mar 2021
View all 12 Funding Rounds on Tracxn Platform

28. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diabetes Drugs
20
28
Back to index
Diabetes (Livongo)
(# Cos: 860 | $9.4B)
Drugs (Pendulum)
(# Cos: 232 | $4.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$624M (▲27.7%)
25(▲38.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$4.9B
159
23
232
24
Pendulum
(2012, United States, $57.0M)
Ocugen
(2013, United States, $18.9M)
Xeris Pharma
(2005, United States, $155M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Kriya Therape.. (2012, United States)
$100M - Series B - Jul 2021
Gmax Biopharm (2010, China)
$78.0M - Series C - Mar 2021
ViaCyte (1999, United States)
$53.9M - Series D - Apr 2021
Carmot Therap.. (2010, United States)
$47.0M - Series C - Sep 2020
Imcyse (2010, Belgium)
$25.8M - Series B - Feb 2021
View all 25 Funding Rounds on Tracxn Platform

29. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Sequencing Equipment
21
29
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$611M (▲63.2%)
11( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
15
$3.0B
46
3
74
9
Life Sciences Platforms and Tools (Thermo Fisher
Scientific)
(# Cos: 9455 | $48.8B)
Instruments (10X Genomics)
(# Cos: 1891 | $9.3B)
Genomics (Nanopore)
(# Cos: 188 | $3.9B)
Nucleic Acid Sequencing (Illumina)
(# Cos: 74 | $3.0B)
Illumina
(1998, United States, $28.0M)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
Nanopore (2005, United Kingdom)
$110M - Series G - Oct 2020
GenapSys (2010, United States)
$70.0M - Series D - Mar 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series C - Jun 2021
GensKey (2017, China)
$34.3M - Series C - Nov 2020
QuantuMDx (2008, United Kingdom)
$15.2M - Series B - Mar 2021
View all 11 Funding Rounds on Tracxn Platform

30. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Pivot Bio (2010, United States)
$430M - Series D - Jul 2021
Antheia (2013, United States)
$73.0M - Series B - Jul 2021
LifeMine Ther.. (2016, United States)
$50.0M - Series B - Jan 2021
Prokarium (2012, United Kingdom)
$21.0M - Series B - Oct 2020
OriCiro Genomics (2018, Japan)
$7.3M - Series B - Jul 2021
Trident Biosc.. (2019, United States)
$150K - Seed - Aug 2020
General Biosystems (2014, China)
Undisclosed - Seed - May 2021
View all 12 Funding Rounds on Tracxn Platform
Synthetic Biology
22
30
Back to index
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Applied Genomics (MyHeritage)
(# Cos: 3794 | $50.5B)
Synthetic Biology (Ginkgo Bioworks)
(# Cos: 66 | $4.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$581M (▲6.9%)
12(▲100%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$4.3B
51
4
66
14
Ginkgo Bioworks
(2009, United States, $796M)
Synlogic Therapeutics
(2013, United States, $34.4M)
Amyris
(2003, United States, $487M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

31. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
At-Home Preventive Genetic Test Kits
23
31
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$579M (▲144%)
7(▼22.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
9
$1.4B
45
1
183
9
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Applied Genomics (23andMe)
(# Cos: 3794 | $50.5B)
Consumer Genomics (MyHeritage)
(# Cos: 768 | $3.7B)
Proactive Healthcare (Everly
Wellness)
(# Cos: 183 | $1.4B)
Everly Wellness
(2015, United States, $305M)
Color
(2013, United States, $391M)
LetsGetChecked
(2014, Ireland, $265M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Everly Wellness (2015, United States)
$175M - Series D - Dec 2020
Color (2013, United States)
$167M - Series D - Jan 2021
LetsGetChecked (2014, Ireland)
$150M - Series D - Jun 2021
Everly Wellness (2015, United States)
$75.0M - Series D - Jan 2021
Digbi Health (2018, United States)
$5.4M - Series A - Mar 2021
GenoPalate (2016, United States)
$4.0M - Series A - Dec 2020
Viome (2016, United States)
$3.0M - Series B - Feb 2021

32. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequencing Instruments
24
32
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$570M (▲218%)
13(▲62.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
10
$1.9B
50
3
91
9
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Enabling Technologies (Moderna)
(# Cos: 1658 | $17.8B)
Instrument Systems (10X Genomics)
(# Cos: 313 | $5.0B)
Nucleic Acid Analysis (Quanterix)
(# Cos: 183 | $2.5B)
Sequencing (Nanopore)
(# Cos: 91 | $1.9B)
Nanopore
(2005, United Kingdom, $1.3B)
LexaGene
(2007, United States)
QuantuMDx
(2008, United Kingdom, $38.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
Nanopore (2005, United Kingdom)
$110M - Series G - Oct 2020
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series C - Jun 2021
Purigen Biosy.. (2012, United States)
$34.4M - Series C - Apr 2021
Hugo Biotech (2017, China)
$32.1M - Series A - Sep 2020
QuantuMDx (2008, United Kingdom)
$15.2M - Series B - Mar 2021
View all 13 Funding Rounds on Tracxn Platform

33. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Proteomic Based Diagnostic Tests
25
33
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$526M (▲633%)
8(▲100%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$1.3B
44
5
87
5
Diagnostics (by Technology) (Medtronic)
(# Cos: 5459 | $44.3B)
Diagnostic Assays and Systems (MyHeritage)
(# Cos: 1613 | $21.1B)
In vitro Diagnostics (Illumina)
(# Cos: 1593 | $21.1B)
Protein-based (Oxford Immunotec)
(# Cos: 361 | $2.8B)
Proteomics (Sera Prognostics)
(# Cos: 87 | $1.3B)
Sera Prognostics
(2008, United States, $258M)
Somalogic
(1999, United States, $664M)
IsoPlexis
(2012, United States, $186M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Somalogic (1999, United States)
$212M - Series E - Dec 2020
Somalogic (1999, United States)
$121M - Series E - Nov 2020
Sera Prognost.. (2008, United States)
$100M - Series E - Apr 2021
IsoPlexis (2012, United States)
$92.5M - Series D - Jan 2021
Travera (2017, United States)
$8.4M - Series A - Apr 2021
Travera (2017, United States)
$4.0M - Series A - Jul 2021
Mursla (2017, United Kingdom)
$547K - Seed - Sep 2020
View all 8 Funding Rounds on Tracxn Platform

34. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Inari (2016, United States)
$208M - Series D - May 2021
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
Pairwise (2017, United States)
$90.0M - Series B - Feb 2021
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
Phylos Biosci.. (2014, United States)
$12.2M - Series C - Apr 2021
CoverCress (2013, United States)
$8.0M - Series B - Mar 2021
Phylos Biosci.. (2014, United States)
$4.5M - Series B - Jan 2021
View all 14 Funding Rounds on Tracxn Platform
Agrigenomics
26
34
Back to index
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Applied Genomics (MyHeritage)
(# Cos: 3794 | $50.5B)
Agrigenomics (Pioneer)
(# Cos: 264 | $3.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$487M (▲186%)
14(▼30%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
34
$3.8B
110
12
264
20
Pioneer
(1935, United States, $1.7B)
Monsanto
(1901, United States)
Limagrain
(1965, France, $200M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

35. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Vedere (2019, United States)
$77.0M - Series A - May 2021
Wuhan Newfoss Biotech.. (2008, China)
$62.0M - Series B - Feb 2021
Stargazer Pha.. (2020, United States)
$57.0M - Series A - Nov 2020
Atsena Therap.. (2020, United States)
$55.0M - Series A - Dec 2020
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
Sydnexis (2014, United States)
$45.0M - Series B - Aug 2021
Phanes Therap.. (2016, United States)
$40.0M - Series B - May 2021
View all 17 Funding Rounds on Tracxn Platform
Retinal Disorders Drugs
27
35
Back to index
Ophthalmology (Zeiss)
(# Cos: 949 | $11.1B)
Drugs (Ocugen)
(# Cos: 305 | $6.4B)
Retinal Disorders (CureVac)
(# Cos: 55 | $1.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$481M (▼32.2%)
17(▲41.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$1.8B
36
7
55
9
CureVac
(2000, Germany, $975M)
Rezolute
(2012, United States)
Molecular Partners
(2004, Switzerland, $59.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

36. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$270M - Series C - Aug 2020
HiFiBiO (2013, France)
$75.0M - Series D - Jun 2021
Denovo Biopha.. (2013, United States)
$45.9M - Series D - Dec 2020
Metabolon (2000, United States)
$21.8M - Series G - Sep 2020
NeoPhore (2017, United Kingdom)
$21.0M - Series B - Mar 2021
NanoBio Designs (2017, United States)
$450K - Seed - Feb 2021
Genomic Biomarker Discovery Research
28
36
Back to index
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Genomics Research (eGenesis Bio)
(# Cos: 169 | $3.7B)
Biomarker Discovery (Freenome)
(# Cos: 78 | $2.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$434M (▲3.2%)
6(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$2.7B
47
5
78
12
Freenome
(2014, United States, $508M)
Metabolon
(2000, United States, $148M)
Lexicon Pharmaceuticals
(1995, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

37. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ophthalmology Drugs
29
37
Back to index
Ophthalmology (Zeiss)
(# Cos: 949 | $11.1B)
Drugs (CureVac)
(# Cos: 305 | $6.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$433M (▲261%)
38(▲52%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
35
$6.4B
218
43
305
40
CureVac
(2000, Germany, $975M)
Ocugen
(2013, United States, $18.9M)
Adverum Biotechnologies
(2006, United States, $70.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Vedere (2019, United States)
$77.0M - Series A - May 2021
Wuhan Newfoss Biotech.. (2008, China)
$62.0M - Series B - Feb 2021
Stargazer Pha.. (2020, United States)
$57.0M - Series A - Nov 2020
Oculis (2003, Switzerland)
$57.0M - Series C - May 2021
Atsena Therap.. (2020, United States)
$55.0M - Series A - Dec 2020
SparingVision (2016, France)
$52.5M - Series C - Oct 2020
View all 38 Funding Rounds on Tracxn Platform

38. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Based Drug Development
Software
30
38
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$397M (▲124%)
8(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$1.3B
41
2
101
8
Life Sciences Tech (Veeva Systems)
(# Cos: 4368 | $22.5B)
Research & Development (Medidata)
(# Cos: 3522 | $18.8B)
Drug Discovery (ATAI)
(# Cos: 992 | $10.8B)
Genomics (Illumina)
(# Cos: 589 | $4.6B)
Drug Development (Insilico)
(# Cos: 101 | $1.3B)
Insilico
(2014, China, $310M)
Brightseed
(2018, United States, $52.0M)
DNAnexus
(2009, United States, $273M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Insilico (2014, China)
$255M - Series C - Jun 2021
LinkDoc (2014, China)
$102M - Series D - Sep 2020
Brightseed (2018, United States)
$27.0M - Series B - Sep 2020
Phenomic AI (2017, Canada)
$6.0M - Seed - Oct 2020
Kinomica (2017, United Kingdom)
$5.2M - Series A - Dec 2020
Mass Dynamics (2015, Australia)
$1.5M - Seed - May 2021
Xbiome (2019, China)
Undisclosed - Series B - Dec 2020
View all 8 Funding Rounds on Tracxn Platform

39. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Metabolic Disorders Drugs
31
39
Back to index
Metabolic Diseases (MannKind Corp)
(# Cos: 386 | $10.3B)
Drugs (Millendo Therapeutics)
(# Cos: 260 | $8.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$387M (▲180%)
32(▲23.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$8.6B
207
59
260
34
Millendo Therapeutics
(2012, United States, $128M)
MannKind Corp
(1991, United States, $50.0M)
Nimbus Therapeutics
(2009, United States, $242M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
VISEN Pharmaceuticals (2018, China)
$150M - Series B - Jan 2021
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Gmax Biopharm (2010, China)
$78.0M - Series C - Mar 2021
View all 32 Funding Rounds on Tracxn Platform

40. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ultrasound Imaging Devices
32
40
Back to index
Imaging Diagnostics (Siemens Healthineers)
(# Cos: 635 | $5.2B)
Ultrasound (Butterfly Network)
(# Cos: 111 | $1.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$384M (▲83.7%)
10(▲100%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.7B
50
5
111
10
Butterfly Network
(2011, United States, $350M)
INSIGHTEC
(1999, Israel, $487M)
Exo
(2015, United States, $346M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Exo (2015, United States)
$220M - Series C - Jul 2021
EchoNous (2015, United States)
$60.0M - Series C - Jun 2021
Exo (2015, United States)
$51.0M - Series C - Nov 2020
Exo (2015, United States)
$40.0M - Series B - Aug 2020
TechsoMed (2012, Israel)
$7.0M - Series B - Mar 2021
Pulsify Medical (2019, Belgium)
$4.5M - Series A - May 2021
MAUI Imaging (2006, United States)
$1.5M - Series B - Mar 2021
View all 10 Funding Rounds on Tracxn Platform

41. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Affinivax (2013, United States)
$226M - Series C - Jan 2021
MicuRx Pharma.. (2007, United States)
$107M - Series E - Dec 2020
Vedanta Biosc.. (2010, United States)
$68.0M - Series D - Jul 2021
Minervax (2010, Denmark)
$57.4M - Series B - Dec 2020
Adaptive Phag.. (2016, United States)
$40.8M - Series B - May 2021
SpyBiotech (2017, United Kingdom)
$32.5M - Series A - Feb 2021
Adrenomed (2009, Germany)
$26.6M - Series E - Nov 2020
View all 23 Funding Rounds on Tracxn Platform
Anti Bacterial Drugs
33
41
Back to index
Infectious Diseases (Oxford Immunotec)
(# Cos: 1856 | $26.2B)
Drugs (Moderna)
(# Cos: 1027 | $21.7B)
Bacterial (Paratek Pharma)
(# Cos: 329 | $5.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$380M (▲48.5%)
23(▼23.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
34
$5.4B
237
36
329
34
Paratek Pharma
(1996, United States, $96.5M)
Locus Biosciences
(2015, United States, $32.3M)
Symbiomix Therapeutics
(2012, United States, $66.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

42. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diagnostics (by Technology) > Diagnostic
Software > Imaging > Digital Pathology
34
42
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$379M (▲153%)
9(▼10%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$864M
43
3
81
8
Diagnostics (by Technology) (Illumina)
(# Cos: 5459 | $44.3B)
Diagnostic Software (Quest Diagnostics)
(# Cos: 629 | $4.8B)
Imaging (Ibex)
(# Cos: 359 | $2.9B)
Digital Pathology (PathAI)
(# Cos: 81 | $864M)
PathAI
(2016, United States, $255M)
Ibex
(2016, Israel, $52.0M)
Definiens
(1994, Germany, $33.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
PathAI (2016, United States)
$165M - Series C - May 2021
PAIGE (2018, United States)
$100M - Series C - Jan 2021
Ibex (2016, Israel)
$38.0M - Series B - Mar 2021
PAIGE (2018, United States)
$25.0M - Series C - Mar 2021
Proscia (2014, United States)
$23.0M - Series B - Nov 2020
Aiforia (2014, Finland)
$15.4M - Series B - Jun 2021
CoreMap (2017, United States)
$10.5M - Series A - Sep 2020
View all 9 Funding Rounds on Tracxn Platform

43. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Artiva (2018, United States)
$120M - Series B - Feb 2021
Caribou Biosc.. (2011, United States)
$115M - Series C - Mar 2021
Trucode Gene .. (2016, United States)
$80.0M - Series C - Jan 2021
Health Gene Technolog.. (2011, China)
$33.4M - Series A - Dec 2020
mRNA (2016, United States)
$10.0M - Seed - Apr 2021
mRNA (2016, United States)
$2.4M - Seed - Aug 2020
Genome Engineering Services
35
43
Back to index
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Genomics Services (Personalis)
(# Cos: 806 | $2.0B)
Genome Engineering (Caribou
Biosciences)
(# Cos: 95 | $542M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$361M (▲211%)
6(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$542M
25
1
95
5
Caribou Biosciences
(2011, United States, $157M)
Artiva
(2018, United States, $198M)
Canopy Biosciences
(2016, United States, $4.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

44. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Molecular Modeling Solutions
36
44
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$361M (▲5153%)
11(▲120%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$440M
45
-
111
4
Life Sciences Tech (Medidata)
(# Cos: 4368 | $22.5B)
Research & Development (Illumina)
(# Cos: 3522 | $18.8B)
Drug Informatics (Benchling)
(# Cos: 687 | $3.0B)
Molecular Modeling (Cellarity)
(# Cos: 111 | $440M)
Cellarity
(2015, United States, $173M)
PharmEnable
(2016, United Kingdom, $2.2M)
Reverie Labs
(2017, United States, $32.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Cellarity (2015, United States)
$123M - Series B - Feb 2021
Stonewise (2018, China)
$100M - Series B - Apr 2021
Entos (2019, United States)
$53.0M - Series A - Jul 2021
Enveda (2019, United States)
$51.0M - Series A - Jun 2021
Reverie Labs (2017, United States)
$25.0M - Series A - Feb 2021
Enveda (2019, United States)
$4.9M - Seed - Dec 2020
Ten63 (2019, United States)
$2.1M - Seed - Jan 2021
View all 11 Funding Rounds on Tracxn Platform

45. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Precision Medicine Software
37
45
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$358M (▲386%)
6(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$723M
16
1
25
4
Diagnostics (by Technology) (Illumina)
(# Cos: 5459 | $44.3B)
Diagnostic Software (PathAI)
(# Cos: 629 | $4.8B)
Bioinformatics (Quest Diagnostics)
(# Cos: 109 | $1.3B)
Precision Medicine (N-of-One)
(# Cos: 59 | $807M)
Therapy Selection (Syapse)
(# Cos: 25 | $723M)
Syapse
(2008, United States, $188M)
N-of-One
(2008, United States, $17.8M)
Turbine
(2015, Hungary, $11.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
3DMed (2010, China)
$224M - Series D - Oct 2020
Syapse (2008, United States)
$68.0M - Series E - Feb 2021
NovellusDx (2011, Israel)
$57.0M - Series C - Sep 2020
Turbine (2015, Hungary)
$6.8M - Seed - Jan 2021
4baseCare (2018, India)
$2.0M - Seed - Mar 2021
3DMed (2010, China)
Undisclosed - Series C - Oct 2020

46. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Biocytogen (2008, United States)
$142M - Series D - Sep 2020
eGenesis Bio (2014, United States)
$125M - Series C - Mar 2021
Interius Biot.. (2020, United States)
$76.0M - Series A - May 2021
Biocytogen (2008, United States)
$10.0M - Series D - Jun 2021
Genomic Research Models
38
46
Back to index
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Genomics Research (Freenome)
(# Cos: 169 | $3.7B)
Research Models (eGenesis Bio)
(# Cos: 44 | $687M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$353M (▲248%)
4(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$687M
20
3
44
3
eGenesis Bio
(2014, United States, $265M)
Biocytogen
(2008, United States, $301M)
GenOway
(1999, France, $11.6M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

47. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diagnostics (by Technology) > Diagnostic Assays and Systems
> In vitro Diagnostics > Multi-omic Assays > Liquid Biopsy
39
47
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$352M (▲899%)
2(▼60%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$874M
9
4
14
2
Diagnostics (by Technology) (Medtronic)
(# Cos: 5459 | $44.3B)
Diagnostic Assays and Systems (MyHeritage)
(# Cos: 1613 | $21.1B)
In vitro Diagnostics (Illumina)
(# Cos: 1593 | $21.1B)
Multi-omic Assays (Biodesix)
(# Cos: 32 | $1.1B)
Liquid Biopsy (Freenome)
(# Cos: 14 | $874M)
Freenome
(2014, United States, $508M)
Biodesix
(2005, United States, $190M)
Biocept
(1993, United States, $53.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Freenome (2014, United States)
$270M - Series C - Aug 2020
Scipher Medic.. (2014, United States)
$82.0M - Series C - Mar 2021

48. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Caribou Biosc.. (2011, United States)
$115M - Series C - Mar 2021
Alchemab (2019, United Kingdom)
$82.7M - Series A - Apr 2021
Bluepha (2014, China)
$61.7M - Series B - Aug 2021
Clear Labs (2014, United States)
$60.0M - Series C - May 2021
Health Gene Technolog.. (2011, China)
$33.4M - Series A - Dec 2020
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
MedGenome (2013, India)
$16.5M - Series D - Jul 2021
View all 27 Funding Rounds on Tracxn Platform
Genomics Research Services
40
48
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9455 | $48.8B)
Research Services (Ginkgo Bioworks)
(# Cos: 4971 | $32.8B)
Genomics (Ancestry)
(# Cos: 660 | $2.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$349M (▲33.7%)
27( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
55
$2.2B
210
17
660
22
Ancestry
(1996, United States, $146M)
Personalis
(2011, United States, $87.3M)
Caribou Biosciences
(2011, United States, $157M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

49. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequence Analysis Softwares
41
49
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$342M (▲16.8%)
13(▼40.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$2.5B
163
10
404
17
Life Sciences Tech (Veeva Systems)
(# Cos: 4368 | $22.5B)
Research & Development (Medidata)
(# Cos: 3522 | $18.8B)
Drug Discovery (ATAI)
(# Cos: 992 | $10.8B)
Genomics (Human Longevity)
(# Cos: 589 | $4.6B)
Sequencing Analysis (Illumina)
(# Cos: 404 | $2.5B)
Illumina
(1998, United States, $28.0M)
Human Longevity
(2013, United States, $330M)
Personalis
(2011, United States, $87.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
CAMP4 (2018, United States)
$45.0M - Series B - Mar 2021
ChromaCode (2012, United States)
$38.6M - Series C - Dec 2020
Genomics (2014, United Kingdom)
$30.0M - Series B - Mar 2021
MedGenome (2013, India)
$16.5M - Series D - Jul 2021
Seven Bridges.. (2009, United States)
$15.0M - Series C - Apr 2021
Eagle Genomics (2008, United Kingdom)
$9.0M - Series B - Oct 2020
View all 13 Funding Rounds on Tracxn Platform

50. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cardiac Diagnostic Devices
42
50
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$339M (▲151%)
10(▼52.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
16
$1.4B
119
12
244
18
Cardiac and Vascular Disorders (Moderna)
(# Cos: 2341 | $29.8B)
Medical Devices (Withings)
(# Cos: 1862 | $19.1B)
Screening Devices (Acutus Medical)
(# Cos: 355 | $2.6B)
Cardiac Diagnostic (Eko)
(# Cos: 244 | $1.4B)
Eko
(2013, United States, $95.0M)
Qardio
(2012, United States, $28.8M)
AliveCor
(2011, United States, $114M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Imperative Care (2015, United States)
$260M - Series D - Jul 2021
Eko (2013, United States)
$65.0M - Series C - Nov 2020
AliveCor (2011, United States)
$65.0M - Series E - Nov 2020
Bertis (2014, South Korea)
$13.5M - Series B - Jun 2021
Peerbridge He.. (2012, United States)
$2.7M - Series B - Aug 2020
Lyfas (2017, India)
$682K - Seed - Oct 2020
Ultromics (2017, United Kingdom)
$272K - Series A - Sep 2020
View all 10 Funding Rounds on Tracxn Platform

51. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Eliem Therape.. (2018, United States)
$80.0M - Series C - Mar 2021
Eliem Therape.. (2018, United States)
$60.0M - Series C - May 2021
Novaremed (2008, Israel)
$50.0M - Series B - Jan 2021
AEON BioPharma (2018, United States)
$30.0M - Series B - Sep 2020
1910 Genetics (2018, United States)
$25.7M - Series A - Mar 2021
Levicept (2012, United Kingdom)
$22.1M - Series B - Nov 2020
Allay Therape.. (2017, United States)
$15.0M - Series B - Jul 2021
View all 20 Funding Rounds on Tracxn Platform
Neurological Pain Management Drugs
43
51
Back to index
Neurology (Biohaven Pharmaceutical)
(# Cos: 2411 | $28.5B)
Drugs (Biogen)
(# Cos: 1308 | $22.1B)
Pain (Zogenix)
(# Cos: 226 | $3.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$333M (▲701%)
20(▲150%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
32
$3.8B
155
38
226
11
Zogenix
(2006, United States, $203M)
Flexion Therapeutics
(2007, United States, $62.0M)
AcelRx
(2005, United States, $22.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

52. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nanoparticle Based Drug Delivery
Systems
44
52
Back to index
Drug Delivery (MannKind Corp)
(# Cos: 694 | $6.9B)
Nanoparticle Based (Acorda)
(# Cos: 206 | $1.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$329M (▲1218%)
10(▲42.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$1.0B
110
16
206
8
Acorda
(1995, United States, $66.5M)
Liquidia
(2004, United States, $90.3M)
Midatech
(2000, United Kingdom, $16.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Elucida Oncol.. (2014, United States)
$44.0M - Series B - Jan 2021
Clene Nanomed.. (2012, United States)
$42.5M - Series D - Aug 2020
Bionaut Labs (2015, United States)
$20.0M - Series B - Mar 2021
Sisaf (2006, United Kingdom)
$13.2M - Series B - Nov 2020
Clene Nanomed.. (2012, United States)
$9.3M - Series D - May 2021
Blueberry Th.. (2011, United Kingdom)
$4.9M - Series B - Feb 2021
View all 10 Funding Rounds on Tracxn Platform

53. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Congestive Heart Failure Treatment
Devices
45
53
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$324M (▲11.9%)
13( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
17
$2.4B
86
7
100
20
Cardiac and Vascular Disorders (Moderna)
(# Cos: 2341 | $29.8B)
Medical Devices (Withings)
(# Cos: 1862 | $19.1B)
Therapeutic Devices (AtriCure)
(# Cos: 978 | $14.4B)
Congestive Heart Failure (Sequena
Medical)
(# Cos: 100 | $2.4B)
Sequena Medical
(2006, Switzerland, $35.5M)
Abiomed
(1981, United States)
SynCardia
(2001, United States, $72.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Ancora Heart (2001, United States)
$80.0M - Series D - Jul 2021
Impulse Dynamics (1996, Germany)
$60.0M - Series D - Jan 2021
CorWave (2011, France)
$43.0M - Series C - Jan 2021
AdjuCor (2008, Germany)
$35.1M - Series B - Jun 2021
V-Wave (2009, Israel)
$28.0M - Series C - Sep 2020
Bivacor (2008, United States)
$19.0M - Series B - May 2021
FineHeart (2010, France)
$18.3M - Series B - Jun 2021
View all 13 Funding Rounds on Tracxn Platform

54. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
RNA Interference Platforms
46
54
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$316M (▼53.8%)
4(▼55.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$4.6B
40
9
61
8
Genomics (Illumina)
(# Cos: 7192 | $79.1B)
Enabling Technologies (Quanterix)
(# Cos: 1658 | $17.8B)
Technology Platforms (Kite Pharma)
(# Cos: 360 | $9.8B)
RNA interference (Moderna)
(# Cos: 61 | $4.6B)
Moderna
(2010, United States, $2.8B)
CureVac
(2000, Germany, $975M)
Dicerna Pharmaceuticals
(2007, United States, $107M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
oRNA (2020, United States)
$80.0M - Series A - Feb 2021
Apic Bio (2017, United States)
$42.3M - Series B - Nov 2020
Gatehouse Bio (2016, United States)
$5.4M - Series A - Jan 2021

55. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Patient Recruitment Platforms for
Clinical Trials
47
55
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$314M (▲372%)
9(▼10%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
10
$707M
67
-
198
9
Life Sciences Tech (Veeva Systems)
(# Cos: 4368 | $22.5B)
Research & Development (Illumina)
(# Cos: 3522 | $18.8B)
Clinical Trials (Medidata)
(# Cos: 920 | $3.1B)
Scientific Sourcing (myTomorrows)
(# Cos: 234 | $838M)
Patients (PatientsLikeMe)
(# Cos: 198 | $707M)
PatientsLikeMe
(2004, United States, $151M)
myTomorrows
(2012, Netherlands, $22.3M)
Reify Health
(2012, United States, $258M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Reify Health (2012, United States)
$220M - Series C - Aug 2021
PatientsLikeMe (2004, United States)
$26.0M - Series D - Feb 2021
Antidote (2008, United Kingdom)
$23.2M - Series C - Jun 2021
Mendel Health (2016, United States)
$18.0M - Series A - Jun 2021
HealthMatch (2016, Australia)
$13.4M - Series B - Dec 2020
SiteRx (2008, United States)
$6.1M - Series A - Sep 2020
BEKHealth (2016, United States)
$4.6M - Series A - Jun 2021
View all 9 Funding Rounds on Tracxn Platform

56. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
LianBio (1999, China)
$310M - Unattributed - Oct 2020
LianBio (1999, China)
$3.0M - Seed - Apr 2021
Valvular Disorder Drugs
48
56
Back to index
Cardiac and Vascular Disorders (Withings)
(# Cos: 2341 | $29.8B)
Drugs (Moderna)
(# Cos: 321 | $9.9B)
Valvular Disorders (LianBio)
(# Cos: 2 | $313M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$313M ( -- )
2( -- )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$313M
2
-
2
1
LianBio
(1999, China, $313M)
Spark Biopharma
(2016, South Korea)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

57. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Esco (1978, United States)
$200M - Series A - May 2021
Truvian (2015, United States)
$105M - Series C - Feb 2021
Dawei (2019, China)
Undisclosed - Seed - Mar 2021
Jiangsu Sanlian Bioen.. (2007, China)
Undisclosed - Series A - Nov 2020
Life Sciences Research Instruments
49
57
Back to index
Life Sciences Platforms and Tools (Thermo Fisher
Scientific)
(# Cos: 9455 | $48.8B)
Instruments (Illumina)
(# Cos: 1891 | $9.3B)
Diversified (10X Genomics)
(# Cos: 367 | $782M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$305M (▲1026%)
4(▲300%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
41
$782M
80
15
367
2
10X Genomics
(2012, United States, $274M)
Beckman Coulter
(1935, United States)
Bruker
(1960, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

58. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cancer Precision Medicine Diagnostic
Tests
50
58
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$297M (▲423%)
12(▲140%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$595M
28
2
44
6
Oncology (Moderna)
(# Cos: 4274 | $93.1B)
In-Vitro Diagnostic Tests (Adaptive
Biotechnologies)
(# Cos: 1094 | $17.6B)
Diversified (Guardant Health)
(# Cos: 476 | $8.8B)
Precision Medicine (Personalis)
(# Cos: 44 | $595M)
Personalis
(2011, United States, $87.3M)
HalioDx
(2015, France, $31.3M)
OncoDNA
(2012, Belgium, $37.4M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
ITM (2004, Germany)
$109M - Series D - Apr 2021
Scipher Medic.. (2014, United States)
$82.0M - Series C - Mar 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
CytoSite Bio (2016, United States)
$3.0M - Series A - Sep 2020
Swiss Nuclides (2017, Switzerland)
$2.8M - Seed - Jun 2021
PreComb (2018, Switzerland)
$2.4M - Seed - Apr 2021
View all 12 Funding Rounds on Tracxn Platform

59. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Recent funding rounds
Investment Trends
Most Active Investors
Top Funded Business Models
Explore more on Tracxn
All Tech Companies
US Tech Companies
Online Travel Companies
Companies using AI in Healthcare
Companies founded by Stanford GSB Alumni
Soonicorn club in Fintech
Analyst Picks in Israel Tech
Key News in FinTech
Events in Bay Area
Angel Investors in United States
Bluebox
Companies Investment Activity
Miscellaneous
Company Detail Page of DoorDash
Competitors of Freshworks
Cap Table for TransferWise
Financials for Ola
Employee Count for Revolut
Company Due Diligence Exits
Public Companies
Acquired Companies
Most Active Acquirers
Reports
Delhivery - Company Report
Novel Foods - Business Model Report
HRTech - Feed Report
FinTech - Top Business Models Report
US Tech - Top Business Models Report
US Tech - Monthly Report
59

60. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Explore other Reports on Tracxn
HRTech
InsurTech
Food Tech
Novel Foods
Blockchain Network
P2P Remittance
Business Model Reports
FinTech Europe
Consumer Digital SEA
HiTech US
Feed Geo Reports
Company Reports
Monthly Unicorn Report
Unicorn Reports
Transferwise
Coursera
BigBasket
Feed Reports Top Business Models in PA
FinTech
Enterprise Applications
Artificial Intelligence
Geo Monthly Reports
US Tech
Europe Tech
China Tech
Top Business Models in Geo
India Tech
Israel Tech
UK & Ireland Tech
60

61. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Life Sciences - Top Business Models Report
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn Technologies Private Limited including but not limited to the
information contained herein ("Data") is the sole property of Tracxn Technologies Private Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or
sell the Data or any portion thereof in any form or by any means, either for commercial or non-commercial use, or permit any third party to use or distribute the Data or any
portion thereof; to any other party, except with the prior written consent of Tracxn. You may however incorporate insubstantial portions, extracts, abstracts or summaries from the
Data into analysis, presentations or tools for your customers or for your internal use, so long as Tracxn is clearly and visibly identified as the source of information.
For further information please refer to our Terms of Use at www.tracxn.com